Beam Therapeutics Inc. ( BEAM) - Stock Earnings
BEAM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 4, 2026, midnight | — / — | — | — / — | — |
BEAM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -112.7 million USD | 9.7 million USD |
| 2025Q4 | 244.3 million USD | 114.1 million USD |
| 2026Q1 | -94.3 million USD | 31.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
BEAM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -132.5 million USD | 377.7 million USD |
| 2024 | -376.7 million USD | 63.5 million USD |
| 2025 | -80.0 million USD | 139.7 million USD |
| 2026 Est. | — | — |
BEAM
Price: $25.10
Earnings Per Share: -0.49 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Market Capitalization: 3.6 billion